Organisatie

dhr. prof. dr. B.A. (Ben) Schmand


  • Faculteit der Maatschappij- en Gedragswetenschappen
    Programmagroep: Brain & Cognition
  • Weesperplein  4
    1018 XA  Amsterdam
  • B.A.Schmand@uva.nl
    T:  0205256849

Biography

Ben Schmand studied psychology and philosophy at the University of Amsterdam. He obtained a master's degree in clinical and experimental psychology in 1978. During the next 20 years he practiced as a clinical psychologist and neuropsychologist at the Slotervaart hospital in Amsterdam and in several other general and psychiatric hospitals. In parallel he held various research positions at the University of Amsterdam, the University of Utrecht, and the Free University in Amsterdam. He obtained a PhD in 1991 at the University of Utrecht under the supervision of professors Betto Deelman and Marten Kuilman. In 1997 he joined the neurological department of the Academic Medical Center in Amsterdam. In 2003 he was appointed as professor of clinical neuropsychology at the University of Amsterdam.

Research

With few exceptions his research has always involved applied neuropsychological topics such as development of new neuropsychological tests, improving the efficiency of neuropsychological assessment, delineating the cognitive profile of neurological and psychiatric diseases, and neuropsychological (side) effects of medical treatments. His recent and current research focuses on Alzheimer's disease and other dementias, Parkinson's disease and other movement disorders, meningitis, substance abuse, schizophrenia, and the validity of mental symptoms in chronic conditions like painter's disease and whiplash.

Neuropsychologie studeren?

Voor informatie over het vak van klinisch neuropsycholoog en over de studieroute Klinische neuropsychologie: klik op onderstaande link.

Tests

Schmand B, Lindeboom J, van Harskamp F: Dutch Adult Reading Test. Lisse, Swets en Zeitlinger, 1992.
Lindeboom J, Schmand B. Visual Association Test. PITS Leiden, 2003.
Schmand B, Lindeboom J. The Amsterdam Short Term Memory Test . PITS Leiden, 2005.

Reprints

Books

  • Eling P, de Haan E, Hijman R, Schmand B. (Eds.) Cognitieve neuropsychiatrie. Uitgeverij Boom, Amsterdam, 2003.
  • Marc Hendriks, Roy Kessels, Mariëlle Gorissen, Ben Schmand (redactie). Neuropsychologische d iagnostiek. De klinische praktijk.  Uitgeverij Boom, Amsterdam, 2006.
  • Bouma A, Mulder J, Lindeboom J, Schmand B. (Eds.) Handboek neuropsychologische diagnostiek (2e herziene druk).  Pearson, Amsterdam, 2012.


Publications (Dutch and international, peer reviewed)

  • Kylstra WA, Aaronson JA, Hofman WF, Schmand BA. Neuropsychological functioning  after CPAP treatment in obstructive sleep apnea: A meta-analysis. Sleep Med Rev. 2012 Oct 11. 
  • Visser I, de Boer AG, Wekking EM, van Vliet J, Van Hout MS, Schmand B, van der Laan G, Schene AH, van Dijk FJ. The Coping with Attention and Memory Complaints Questionnaire (CAMQ): Psychometric evaluation of an instrument in suspected chronic solvent-induced encephalopathy (CSE). Neuropsychol Rehabil. 2012 Oct;22(5):794-808.
  • Raaphorst J, Beeldman E, Schmand B, Berkhout J, Linssen WH, van den Berg LH, Pijnenburg YA, Grupstra HF, Weikamp JG, Schelhaas HJ, Papma JM, van Swieten JC, de Visser M, de Haan RJ. The ALS-FTD-Q: A new screening tool for behavioral disturbances in ALS. Neurology. 2012 Sep 25;79(13):1377-83.
  • Richard E, Schmand B, Eikelenboom P, Westendorp RG, Van Gool WA. The Alzheimer myth and biomarker research in dementia. J Alzheimers Dis. 2012 Jan 1;31(0):S203-9.
  • Raaphorst J, Beeldman E, Jaeger B, Schmand B, van den Berg LH, Weikamp JG, Schelhaas HJ, de Visser M, de Haan RJ. Is the Frontal Assessment Battery reliable in ALS patients? Amyotroph Lateral Scler. 2012 Aug 13.


  • Richard E, Schmand B, Eikelenboom P, Yang SC, Ligthart SA, Moll van Charante EP, van Gool WA; Alzheimer's Disease Neuroimaging Initiative. Symptoms of apathy  are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Dement Geriatr Cogn Disord. 2012;33(2-3):204-9.
  • van Tricht MJ, Dreissen YE, Cath D, Dijk JM, Contarino MF, van der Salm SM, Foncke EM, Groen JL, Schmand B, Tijssen MA. Cognition and psychopathology in myoclonus-dystonia. J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):814-20.
  • Pires C, Silva D, Maroco J, Ginó S, Mendes T, Schmand BA, Guerreiro M, de Mendonça A. Memory complaints associated with seeking clinical care. Int J Alzheimers Dis. 2012;2012:725329.
  • Goudsmit M, Parlevliet JL, van Campen JP, Schmand B. [Diagnosis of dementia in non-western elderly migrants in memory clinics: obstacles and solutions]. Tijdschr Gerontol Geriatr. 2011 Oct;42(5):204-14.
  • Raaphorst J, Beeldman E, De Visser M, De Haan RJ, Schmand B. A systematic review of behavioural changes in motor neuron disease. Amyotroph Lateral Scler. 2012 Oct;13(6):493-501.
  • Schmand B, Eikelenboom P, van Gool WA; Alzheimer's Disease Neuroimaging Initiative. Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment. J Alzheimers Dis. 2012;29(3):641-8.
  • Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012 Mar;27(3):349-56.
  • Wouters H, Appels B, van derFlier WM, van Campen J, Klein M, Zwinderman AH, Schmand B, van Gool WA, Scheltens P, Lindeboom R. Improving the Accuracy and Precision of Cognitive Testing in Mild Dementia. J Int Neuropsychol Soc. 2011 Dec 30:1-9. 
  • Schmand B, Eikelenboom P, van Gool WA; the Alzheimer's Disease Neuroimaging Initiative. Value of Neuropsychological Tests, Neuroimaging, and Biomarkers for Diagnosing Alzheimer's Disease in Younger and Older Age Cohorts. J Am Geriatr Soc. 2011 Sep;59(9):1705-1710. doi: 10.1111/j.1532-5415.2011.03539.x.
  • Holwerda TJ, Beekman AT, Deeg DJ,Stek ML, van Tilburg TG, Visser PJ, Schmand B, Jonker C, Schoevers RA. Increased risk of mortality associated with social isolation in older men: only when feeling lonely? Results from the Amsterdam Study of the Elderly (AMSTEL). Psychol Med. 2011 Sep 6:1-11.
  • Slor CJ, de Jonghe JF, Vreeswijk R, Groot E, Ploeg TV, van Gool WA, Eikelenboom P, Snoeck M, Schmand B, Kalisvaart KJ. Anesthesia and postoperative delirium in older adults undergoing hip surgery. J Am Geriatr Soc. 2011 Jul;59(7):1313-9.
  • Wouters H, van Campen J, Appels B, Lindeboom R, Buiter M, de Haan RJ, Zwinderman AH, van Gool WA, Schmand B. Does adaptive cognitive testing combine efficiency with precision? Prospective findings. J Alzheimers Dis. 2011;25(4):595-603.
  • Post B, Muslimovic D, van Geloven N, Speelman JD, Schmand B, de Haan RJ; CARPA-study group. Progression and prognostic factors ofmotor impairment, disability and quality of life in newly diagnosed Parkinson's disease. Mov Disord. 2011 Feb 15;26(3):449-56.
  • Hoogland J, de Bie RM, Williams-Gray CH, MuslimovićD, Schmand B, Post B. Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease. Mov Disord. 2010 Nov 15;25(15):2550-4.
  • Raaphorst J, de Visser M, van Tol MJ, Linssen WH, van der Kooi AJ, de Haan RJ, van den Berg LH, Schmand B. Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy. J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):170-5.
  • Wouters H, Appels B, Van Campen J, Lindeboom R, Buiter M, Zwinderman AH, van Gool WA, Schmand B. Adaptive testing combines precision with brevity in the grading of cognitive impairment. Behav Neurol. 2010;23(4):181-3.
  • Wouters H, de Koning I, Zwinderman AH, van Gool WA, Schmand B, Buiter M, Lindeboom R. Adaptive cognitive testing in cerebrovascular disease and vascular dementia. Dement Geriatr Cogn Disord. 2009;28(5):486-92.
  • Schmand B, de Bruin E, de Gans J, van de Beek D. Cognitive functioning and quality of life nine years after bacterial meningitis. J Infect. 2010;61(4):330-4.
  • van Tricht MJ, Smeding HM, Speelman JD, Schmand BA. Impaired emotion recognition in music in Parkinson's disease. Brain Cogn. 2010 Oct;74(1):58-65.
  • Rienstra A, Spaan PE , Schmand B. Validationof symptom validity tests using a "child-model" of adult cognitive impairments. Arch Clin Neuropsychol. 2010 Aug;25(5):371-82.
  • Raaphorst J, Grupstra HF, Linssen WH, van Swieten JC, Schmand B, de Visser M. [Amyotrophic lateral sclerosis en frontotemporal dementia: overlapping  characteristics]. NedTijdschr Geneeskd. 2010;154:A631.
  • Wouters H, van Gool WA , Schmand B, Zwinderman AH, Lindeboom R. Three sides of the same coin: measuring global cognitive impairment with the MMSE, ADAS-cog and CAMCOG. Int J Geriatr Psychiatry. 2010 Aug;25(8):770-9.
  • Schilt T, Koeter MW, Smal JP, Gouwetor MN, van den Brink W, Schmand B. Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users. Psychopharmacology (Berl). 2010 Jan;207(4):583-91.
  • Schmand B, Huizenga HM, van Gool WA. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease. Psychol Med. 2010 Jan;40(1):135-45.
  • Wouters H, de Koning I, Zwinderman AH, van Gool WA , Schmand B, Buiter M, Lindeboom R. Adaptive Cognitive Testing in Cerebrovascular Disease and Vascular Dementia. Dement Geriatr Cogn Disord. 2009 Nov 27;28(5):486-492.
  • Ginó S, Mendes T, Maroco J, Ribeiro F, Schmand BA, de Mendonça A, Guerreiro M. Memory Complaints Are Frequent but Qualitatively Different in Young and Elderly Healthy People. Gerontology. 2009 Sep 17. [Epubahead of print]
  • Rienstra A, Spaan PE , Schmand B. Reference data for the word memory test. Arch Clin Neuropsychol. 2009 May;24(3):255-62.
  • Wouters H, Zwinderman AH, van Gool WA , Schmand B, Lindeboom R. Adaptive cognitive testing in dementia. Int J Methods Psychiatr Res. 2009 Jun;18(2):118-27.
  • Foncke EM, Cath D, Zwinderman K, Smit J, Schmand B, Tijssen M. Is psychopathology part of the phenotypic spectrum of myoclonus-dystonia?: a study of a large Dutch M-D family. Cogn Behav Neurol. 2009 Jun;22(2):127-33.
  • Smeding HM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson Disease. J Neurol Neurosurg Psychiatry. 2009 May 21. [Epub ahead of print]
  • Muslimović D, Post B, Speelman JD, De Haan RJ, Schmand B. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc. 2009 May;15(3):426-37.
  • van Hooff JC, Sargeant E, Foster JK, Schmand BA. Identifying deliberate attempts to fake memory impairment through the combined use of reaction time and event-related potential measures. Int J Psychophysiol. 2009 Sep;73(3):246-56.
  • Raaphorst J, De Visser M, Linssen WH, De Haan RJ, Schmand B. The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis. Amyotroph Lateral Scler. 2009 Jan 29:1-13.
  • Schilt T, Koeter MW, deWin MM, Zinkstok JR, van Amelsvoort TA, Schmand B, den Brink W. The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene. Eur Neuropsychopharmacol. 2009 Feb;19(2):116-24.
  • Schilt T, Goudriaan AE, Koeter MW, van den Brink W, Schmand B. Decision making as a predictor of first ecstasy use: a prospective study. Psychopharmacology (Berl). 2009 Apr;203(3):519-27.
  • Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ; CARPA Study Group. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008 Jun 3;70(23):2241-7.
  • Wouters H, van Gool WA, Schmand B, Lindeboom R.  Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):236-44.
  • Schilt T, Goudriaan AE, Koeter MW, van den Brink W, Schmand B. Decision making as a predictor of first ecstasy use: aprospective study. Psychopharmacology (Berl). 2009 Apr;203(3):519-27.
  • Schilt T, Koeter MW, de Win MM, Zinkstok JR, van Amelsvoort TA, Schmand B, den Brink W. The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene. Eur Neuropsychopharmacol. 2009 Feb;19(2):116-24.
  • Raaphorst J, De Visser M, Linssen WH, De Haan RJ, Schmand B.  The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis. Amyotroph Lateral Scler. 2009 Jan 29:1-13.
  • Schmand B, GroeninkSC, van den Dungen M. Letterfluency: psychometrische eigenschappenen Nederlandse normen. Tijdschr Gerontol Geriatrie 2008 Apr 2008; 39: 64-76.
  • Schmand BA,de Jonghe JF, Merckelbach HL. Een patiënt die wilsonbekwaamheid simuleert en voor wie somatische behandeling is geïndiceerd. Letter to the editor. Ned Tijdschr Geneeskd. 2008 Jan 19;152(3):174-5; author reply 175. 
  • Lemstra AW, Kuiper RB, Schmand B, van Gool WA.  Identification of responders to rivastigmine: a prospective cohort study. Dement Geriatr Cogn Disord. 2008;25(1):60-6.
  • Schilt T, Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol Med. 2007 Nov 8;:1-9
  • Muslimović D, Schmand B, Speelman JD, de Haan RJ. Course of cognitive decline in Parkinson's disease: a meta-analysis. J Int Neuropsychol Soc. 2007 Nov;13(6):920-32.
  • Muslimovic D, Post B, Speelman JD, Schmand B. Motor procedural learning in Parkinson's disease. Brain. 2007 Nov;130(Pt11):2887-97.
  • Schilt T, de Win MM, Koeter M,Jager G, Korf DJ, van den Brink W, Schmand B. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry. 2007 Jun;64(6):728-36.
  • Merten T, Bossink L, Schmand B. On the limits of effort testing: symptom validity tests and severity of neurocognitive symptoms innonlitigant patients. J Clin Exp Neuropsychol. Huizenga HM, Smeding H, Grasman RP, Schmand B. Multivariate normative comparisons. Neuropsychologia. 2007;45(11):2534-42.
  • Smeding HM, vanden Munckhof P, Esselink RA, Schmand B, SchuurmanPR, Speelman JD. Reversible cognitive decline after DBS STN in PD and displacement of electrodes. Neurology. 2007 Apr 10;68(15):1235-6. 
  • Hoogman M, van de Beek D, Weisfelt M, de Gans J, Schmand B. Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry. 2007 Oct; 78 ( 10 ): 1092-6 .
  • Speelman JD, Smeding HM, Schmand B. Does chronic subthalamic nucleus stimulation in advanced Parkinson'sdisease cause invalidating cognitive and behavioural dysfunctions? J Neurol Neurosurg Psychiatry. 2007Mar;78(3):221. 
  • Smeding HM, Goudriaan AE, Foncke EM, Schuurman PR, Speelman JD, Schmand B.   Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry. 2007 May;78(5):517-9. 
  • Frankfort SV, Appels BA, de Boer A, Tulner LR, van Campen JP, Koks CH, Beijnen JH, Schmand BA. Identification of responders and reactive domains to rivastigmine inAlzheimer'sdisease. Pharmacoepidemiol Drug Saf. 2007 May;16(5):545-51.
  • Weisfelt M, Hoogman M, vande Beek D, de Gans J, Dreschler WA, Schmand BA.   Dexamethasone and long-term outcome inadults with bacterial meningitis. Ann Neurol. 2006 Oct;60(4):456-68.
  • Weisfelt M, van de Beek D, Hoogman M, Hardeman C, de Gans J, Schmand B.   Cognitive outcome inadults with moderate disability after pneumococcal meningitis. J Infect. 2006 Jun;52(6):433-9.   
  • Weisfelt M, Hoogman M, van de Beek D, de Gans J, Dreschler WA, Schmand BA.   Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol. 2006 Oct;60(4):456-68.
  • Reneman L, Schilt T, de Win MM, Booij J, van den Brink W, Schmand B, Bakker O.Memoryfunction and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. J Psychopharmacology,  2006;20(3):389-99.  
  • Smeding HM, Speelman JD, Koning-Haanstra M, Schuurman PR, Nijssen P, van Laar T, Schmand B. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology. 2006;66(12):1830-6.
  • van de Beek D, Weisfelt M, Hoogman M, de Gans J, Schmand B. Neuropsychological sequelae of bacterial meningitis: the influence of alcoholism and adjunctive dexamethasone therapy. Brain. 2006;129(Pt 5):E46.
  • van Hout MSE, Schmand B, Wekking EM, Deelman BG. Cognitive functioning in patients with suspected chronic toxic encephalopathy: evidence for neuropsychogical disturbances after controlling for insufficient effort. J Neurol Neurosurg Psychiatry 2006;77:296-303.  Muslimovic D, Post B, Speelman JD,Schmand B.Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65(8):1239-45.
  • Gorissen M, Sanz de la Torre, JC, Schmand B. Effort and cognition in schizophrenia patients. Schizophrenia Research 2005;78(2-3):199-208. 
  • Smeding HM, Esselink RA, Schmand B, Koning-Haanstra M, Nijhuis I, Wijnalda EM, Speelman JD. Unilateral pallidotomyversus bilateral subthalamic nucleus stimulation in PD. A comparison of neuropsychological effects. J Neurol. 2005;252(2):176-82.  
  • Lindeboom R, Schmand B, Holman R etal. Improved brief assessment of cognition in aging and dementia. Neurology. 2004;63:543-546
  • Meulen EF, Schmand B, van CampenJP et al.The seven minute screen: a neurocognitive screening test highly sensitive to various types ofdementia. J Neurol Neurosurg Psychiatry. 2004;75:700-705
  • van Alem AP, de Vos R, Schmand B, Koster RW. Cognitive impairment in survivors of out-of-hospital cardiac arrest. Am Heart J. 2004;148:416-421
  • van HoutMS, Schmand B, Wekking EM et al. Suboptimal performance on neuropsychologicaltests in patients with suspected chronic toxicencephalopathy.Neurotoxicology. 2003;24:547-551
  • Bolan B, Foster JK, Schmand B, Bolan S. A comparison of three tests to detect feigned amnesia: the effects of feedback and the measurement of response latency. J Clin Exp Neuropsychol. 2002;24:154-167
  • Doheny DO, Brin MF, Morrison CE et al. Phenotypic features of myoclonus-dystonia inthree kindreds. Neurology. 2002;59:1187-1196
  • Lindeboom J, Schmand B, Tulner Letal. Visual association test to detectearly dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry. 2002;73:126-133
  • van de Beek D, Schmand B, de Gans J etal. Cognitive impairment in adults with good recovery after bacterialmeningitis. JInfect Dis. 2002;186:1047-1052
  • de Bie RM, Schuurman PR, Bosch DA et al. Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patients. J Neurol Neurosurg Psychiatry.2001;71:375-382
  • Reneman L, Lavalaye J, Schmand B etal. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine(MDMA or "ecstasy"): preliminary findings. Arch GenPsychiatry. 2001;58:901-906
  • Reneman L, Majoie CB, SchmandB et al. Prefrontal N-acetylaspartate is strongly associated with memory performance in(abstinent) ecstasy users: preliminary report. BiolPsychiatry. 2001;50:550-554
  • Geerlings MI,Schmand B, Braam AW etal. Depressive symptoms andrisk of Alzheimer's disease inmorehighly educated older people.J Am Geriatr Soc. 2000;48:1092-1097
  • Geerlings MI, Schoevers RA, Beekman AT et al. Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry. 2000;176:568-575
  • Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry. 2000;15:983-991
  • Reneman L, Booij J, Schmand B et al. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology (Berl). 2000;148:322-324
  • Schmand B, de Bie RM, Koning-Haanstra M et al. Unilateralpallidotomy in PD: a controlled study of cognitive and behavioral effects.The Netherlands Pallidotomy Study (NEPAS) group. Neurology. 2000;54:1058-1064
  • Schmand B, Walstra G, Lindeboom J et al. Early detection of Alzheimer's disease using the Cambridge Cognitive Examination (CAMCOG). Psychol Med. 2000;30:619-627
  • de Bie RM, deHaanRJ, Nijssen PC et al. Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet. 1999;354:1665-1669
  • Geerlings MI, Deeg DJ, Penninx BW et al. Cognitivereserve and mortality in dementia: the role of cognition, functional ability and depression. Psychol Med. 1999;29:1219-1226
  • Geerlings MI, Jonker C, Bouter LM etal. Associationbetween memory complaints and incident Alzheimer'sdisease in elderly peoplewith normal baseline cognition. Am J Psychiatry. 1999;156:531-537
  • Geerlings MI,Schmand B, Jonker C et al. Education and incident Alzheimer's disease: a biased association due to selective attrition and use of a two-step diagnostic procedure? Int J Epidemiol. 1999;28:492-497
  • Schmand B, GouwenbergB, Smit JH, Jonker C. Assessment of mental competency incommunity-dwelling elderly. Alzheimer Dis Assoc Disord. 1999;13:80-87
  • Smits CH, Deeg DJ, Kriegsman DM, SchmandB. Cognitive functioning andhealth as determinants of mortality in an older population. Am J Epidemiol. 1999;150:978-986
  • VisserPJ, Scheltens P, Verhey FR et al. Medial temporal lobeatrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol.1999;246:477-485
  • Jonker C, Schmand B, LindeboomJ et al. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol. 1998;55:1065-1069
  • Schmand B, GeerlingsMI, Jonker C, Lindeboom J. Readingability as an estimator of premorbid intelligence: doesitremain stable in emergent dementia? J Clin Exp Neuropsychol. 1998;20:42-51
  • Schmand B, HooijerC, Jonker C et al. Apolipoprotein E phenotype is not related to late-life depression in a population-based sample. Soc Psychiatry Psychiatr Epidemiol.1998;33:21-26
  • Schmand B, Lindeboom J, Schagen S et al. Cognitive complaints in patients after whiplashinjury: the impact of malingering. J Neurol Neurosurg Psychiatry. 1998;64:339-343
  • Geerlings MI, DeegDJ, Schmand B et al. Increased risk of mortality in Alzheimer's disease patients with higher education? A replication study. Neurology. 1997;49:798-802
  • Schagen S,Schmand B, de SterkeS,Lindeboom J.Amsterdam Short-Term Memory test:a newprocedure for the detection of feigned memory deficits.J Clin Exp Neuropsychol. 1997;19:43-51
  • Schmand B, Jonker C, Geerlings MI, Lindeboom J.Subjectivememory complaints in the elderly: depressive symptoms and future dementia. Br J Psychiatry. 1997;171:373-376
  • Schmand B, Smit J, Lindeboom J et al. Low education is a genuine risk factor for accelerated memory decline and dementia. J Clin Epidemiol.1997;50:1025-1033
  • SchmandB, Smit JH, Geerlings MI, Lindeboom J. The effects of intelligence and education onthe development of dementia. A test of the brain reserve hypothesis. PsycholMed. 1997;27:1337-1344
  • Smit JH, Deeg DJ, Schmand BA. Asking the age question in elderlypopulations: a reverse record check study. J Gerontol B Psychol Sci Soc Sci. 1997;52:P175-177
  • Lindeboom J, Launer LJ, Schmand BA et al. Effects of adjustment on the case-finding potential of cognitive tests. J Clin Epidemiol. 1996;49:691-695
  • Schmand B, Jonker C, Hooijer C, Lindeboom J. Subjective memory complaints may announce dementia. Neurology. 1996;46:121-125
  • Schmand B, Lindeboom J, Hooijer C, Jonker C. Relation between education and dementia:therole of test bias revisited. J Neurol NeurosurgPsychiatry. 1995;59:170-174
  • Schmand B, Kuipers T, Van der Gaag M et al. Cognitive disorders and negative symptoms as correlates of motivational deficits in psychotic patients. PsycholMed. 1994;24:869-884
  • Schmand B, Brand N, Kuipers T. Procedural learning of cognitive and motor skills in psychotic patients. Schizophr Res.1992;8:157-170
  • Schmand B, Kop WJ, Kuipers T,Bosveld J. Implicit learning in psychotic patients. Schizophr Res. 1992;7:55-64
  • Schmand B,Neuvel J, Smolders-de Haas H et al. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics.1990;86:58-64
  • Smolders-de Haas H, NeuvelJ,Schmand B et al. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12-year follow-up. Pediatrics. 1990;86:65-70

Neuropsychologie studeren?

Wat is neuropsychologie ?
Wat kun je met klinische neuropsychologie?
    Waar werken klinisch neuropsychologen?
    Wat doet een klinisch neuropsycholoog?
    Hoe word je klinisch neuropsycholoog?
W aarom klinische neuropsychologie studeren aan de UvA?
Hoe ziet de studieroute er uit?
Bachelor in een andere richting?
Bachelor van een andere universiteit?

2015

2014

2013

2012

2011

2010

2009

2008

  • D. Muslimovic, B. Post, J.D. Speelman, B. Schmand & R.J. de Haan (2008). Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology, 70 (23), 2241-2247.
  • A.W. Lemstra, R.B. Kuiper, B. Schmand & W.A. van Gool (2008). Identification of responders to rivastigmine: a prospective cohort study. Dementia and Geriatric Cognitive Disorders, 25 (1), 60-66.
  • M.J. van Tricht, H.M. Smeding, J.D. Speelman & B. Schmand (2008). Impaired recognition of emotions in music in Parkinson's disease. Movement Disorders, 23 (Suppl. 1), 101-101.
  • J. Raaphorst, J. Linssen, R.J. de Haan, B. Schmand & M. Visser (2008). Cognitive impairment in amyothrophic lateral sclerosis: A meta-analysis. Neurology, 70 (11), A345-A345.
  • B. Post, D. Muslimovic, B. Schmand, H. Speelman & R. den Haan (2008). Determinants of disability and quality of life in mild to moderate Parkinson's disease. Movement Disorders, 23 (1), 1043.
  • S.T. de Bot, D. Nanda, L.D.A Dorresteijn, A.M. van Schaik, G.J. Jobsis, E.C.M. van Gorp, B.A. Schmand & J.F.M. de Jonghe (2008). Een patiënt die wilsonbekwaamheid simuleert en voor wie somatische behandeling is geïndiceerd. Nederlands Tijdschrift voor Geneeskunde, 152 (3), 173-175.
  • T. Schilt, M.M.L. de Win, G. Jager, M.W. Koeter, N.F. Ramsey & B. Schmand (2008). Specific effects of ecstasy and other illicit drugs on cognition in poly-sybstance users. Psychological Medicine, 38 (9), 1309-1317.
  • T. Schilt, M.M. de Win, M. Koeter, G. Jager, D.J. Korf, W. van den Brink & B. Schmand (2008). No evidence of decrease in cognitive function in users of low-dose ecstasy - Reply. Archives of General Psychiatry, 65 (2), 236-237.
  • T. Schilt, M.M.L. de Win, G. Jager, M.W. Koeter, N.F. Ramsey, B. Schmand & W. van den Brink (2008). Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychological Medicine, 38 (9), 1309-1317.
  • B. Schmand, S.C. Groenink & M. van den Dungen (2008). Letterfluency: Psychometrische eigenschappen en Nederlandse normen. Tijdschrift voor Gerontologie en Geriatrie, 39 (2), 65-77.
  • H. Wouters, W.A. van Gool, B. Schmand & R. Lindeboom (2008). Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Disease and Associated Disorders, 22 (3), 236-244.

2013

  • M. Goudsmit, J.L. Parlevliet, J.P.C.M. van Campen & B. Schmand (2013). Diagnosis of dementia in non-western elderly migrants in memory clinics: Obstacles and solutions. Tijdschrift voor Gerontologie en Geriatrie, 43 (5), 204-214.

2012

  • A. Bouma, J. Mulder, J. Lindeboom & B. Schmand (2012). Handboek neuropsychologische diagnostiek. - 2e herz. dr. Amsterdam: Pearson.

2010

2008

  • B. Schmand, S.C. Groenink & M. van den Dungen (2008). Letter fluency: Psychometric properties and Dutch normative data. Tijdschrift voor Gerontologie en Geriatrie, 39 (2), 64-76.

2014

2008

  • P. Eikelenboom, W.A. van Gool, B.A. Schmand & R.C. van der Mast (2008). Delirium, dementie en andere cognitieve stoornissen. In W. Vandereycken, C.A.L. Hoogduin & P.M.G. Emmelkamp (Eds.), Handboek psychopathologie, deel 1: Basisbegrippen (vierde herz. druk) (pp. 63-106). Houten: Bohn, Stafleu van Loghum.

Boekredactie

  • M. Hendriks, R. Kessels, M. Gorissen, B. Schmand & A. Duits (Eds.). (2014). Neuropsychologische diagnostiek: de klinische praktijk. - Herziene ed (Neuropsychologische handboeken). Amsterdam: Boom.
This page has been automatically generated by the UvA-Current Research Information System. If you have any questions about the content of this page, please contact the UBAcoach or the Metis staff of your faculty / institute. To edit your publications login to Personal Metis.
  • Academisch Medisch Centrum
    Klinisch Neuropsycholoog

bewerk